Persons with dispensed medicines; age and sex
| Sex | Ages | Medicine group (ATC) | Periods | Persons with medicines, relative (%) |
|---|---|---|---|---|
| Total male and female | Total age | C01D Vasodilators used in card. diseases | 2024* | 1.38 |
| Total male and female | Total age | M05 Drugs for treatment of bone diseases | 2024* | 1.25 |
| Total male and female | Total age | R03 Drugs for obstruct. airway diseases | 2024* | 8.44 |
| Total male and female | 0 to 14 years | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | R03 Drugs for obstruct. airway diseases | 2024* | 6.27 |
| Total male and female | 15 to 24 years | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 15 to 24 years | M05 Drugs for treatment of bone diseases | 2024* | 0.01 |
| Total male and female | 15 to 24 years | R03 Drugs for obstruct. airway diseases | 2024* | 4.68 |
| Total male and female | 25 to 34 years | C01D Vasodilators used in card. diseases | 2024* | 0.02 |
| Total male and female | 25 to 34 years | M05 Drugs for treatment of bone diseases | 2024* | 0.04 |
| Total male and female | 25 to 34 years | R03 Drugs for obstruct. airway diseases | 2024* | 4.87 |
| Total male and female | 35 to 44 years | C01D Vasodilators used in card. diseases | 2024* | 0.13 |
| Total male and female | 35 to 44 years | M05 Drugs for treatment of bone diseases | 2024* | 0.09 |
| Total male and female | 35 to 44 years | R03 Drugs for obstruct. airway diseases | 2024* | 6.15 |
| Total male and female | 45 to 54 years | C01D Vasodilators used in card. diseases | 2024* | 0.64 |
| Total male and female | 45 to 54 years | M05 Drugs for treatment of bone diseases | 2024* | 0.39 |
| Total male and female | 45 to 54 years | R03 Drugs for obstruct. airway diseases | 2024* | 8.21 |
| Total male and female | 55 to 64 years | C01D Vasodilators used in card. diseases | 2024* | 1.77 |
| Total male and female | 55 to 64 years | M05 Drugs for treatment of bone diseases | 2024* | 1.52 |
| Total male and female | 55 to 64 years | R03 Drugs for obstruct. airway diseases | 2024* | 10.77 |
| Total male and female | 65 to 74 years | C01D Vasodilators used in card. diseases | 2024* | 3.44 |
| Total male and female | 65 to 74 years | M05 Drugs for treatment of bone diseases | 2024* | 3.48 |
| Total male and female | 65 to 74 years | R03 Drugs for obstruct. airway diseases | 2024* | 14.20 |
| Total male and female | 75 years or older | C01D Vasodilators used in card. diseases | 2024* | 6.52 |
| Total male and female | 75 years or older | M05 Drugs for treatment of bone diseases | 2024* | 5.79 |
| Total male and female | 75 years or older | R03 Drugs for obstruct. airway diseases | 2024* | 14.49 |
| Total male and female | 0 to 4 years | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 4 years | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 4 years | R03 Drugs for obstruct. airway diseases | 2024* | 7.36 |
| Total male and female | 5 to 9 years | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 5 to 9 years | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 5 to 9 years | R03 Drugs for obstruct. airway diseases | 2024* | 6.01 |
| Total male and female | 10 to 14 years | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 10 to 14 years | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 10 to 14 years | R03 Drugs for obstruct. airway diseases | 2024* | 5.53 |
| Total male and female | 15 to 19 years | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 15 to 19 years | M05 Drugs for treatment of bone diseases | 2024* | 0.01 |
| Total male and female | 15 to 19 years | R03 Drugs for obstruct. airway diseases | 2024* | 5.00 |
| Total male and female | 20 to 24 years | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 20 to 24 years | M05 Drugs for treatment of bone diseases | 2024* | 0.02 |
| Total male and female | 20 to 24 years | R03 Drugs for obstruct. airway diseases | 2024* | 4.42 |
| Total male and female | 25 to 29 years | C01D Vasodilators used in card. diseases | 2024* | 0.01 |
| Total male and female | 25 to 29 years | M05 Drugs for treatment of bone diseases | 2024* | 0.03 |
| Total male and female | 25 to 29 years | R03 Drugs for obstruct. airway diseases | 2024* | 4.64 |
| Total male and female | 30 to 34 years | C01D Vasodilators used in card. diseases | 2024* | 0.02 |
| Total male and female | 30 to 34 years | M05 Drugs for treatment of bone diseases | 2024* | 0.04 |
| Total male and female | 30 to 34 years | R03 Drugs for obstruct. airway diseases | 2024* | 5.09 |
| Total male and female | 35 to 39 years | C01D Vasodilators used in card. diseases | 2024* | 0.07 |
| Total male and female | 35 to 39 years | M05 Drugs for treatment of bone diseases | 2024* | 0.07 |
| Total male and female | 35 to 39 years | R03 Drugs for obstruct. airway diseases | 2024* | 5.73 |
| Total male and female | 40 to 44 years | C01D Vasodilators used in card. diseases | 2024* | 0.18 |
| Total male and female | 40 to 44 years | M05 Drugs for treatment of bone diseases | 2024* | 0.12 |
| Total male and female | 40 to 44 years | R03 Drugs for obstruct. airway diseases | 2024* | 6.60 |
| Total male and female | 45 to 49 years | C01D Vasodilators used in card. diseases | 2024* | 0.41 |
| Total male and female | 45 to 49 years | M05 Drugs for treatment of bone diseases | 2024* | 0.22 |
| Total male and female | 45 to 49 years | R03 Drugs for obstruct. airway diseases | 2024* | 7.65 |
| Total male and female | 50 to 54 years | C01D Vasodilators used in card. diseases | 2024* | 0.84 |
| Total male and female | 50 to 54 years | M05 Drugs for treatment of bone diseases | 2024* | 0.53 |
| Total male and female | 50 to 54 years | R03 Drugs for obstruct. airway diseases | 2024* | 8.70 |
| Total male and female | 55 to 59 years | C01D Vasodilators used in card. diseases | 2024* | 1.40 |
| Total male and female | 55 to 59 years | M05 Drugs for treatment of bone diseases | 2024* | 1.12 |
| Total male and female | 55 to 59 years | R03 Drugs for obstruct. airway diseases | 2024* | 9.90 |
| Total male and female | 60 to 64 years | C01D Vasodilators used in card. diseases | 2024* | 2.15 |
| Total male and female | 60 to 64 years | M05 Drugs for treatment of bone diseases | 2024* | 1.92 |
| Total male and female | 60 to 64 years | R03 Drugs for obstruct. airway diseases | 2024* | 11.66 |
| Total male and female | 65 to 69 years | C01D Vasodilators used in card. diseases | 2024* | 2.99 |
| Total male and female | 65 to 69 years | M05 Drugs for treatment of bone diseases | 2024* | 2.96 |
| Total male and female | 65 to 69 years | R03 Drugs for obstruct. airway diseases | 2024* | 13.66 |
| Total male and female | 70 to 74 years | C01D Vasodilators used in card. diseases | 2024* | 3.96 |
| Total male and female | 70 to 74 years | M05 Drugs for treatment of bone diseases | 2024* | 4.09 |
| Total male and female | 70 to 74 years | R03 Drugs for obstruct. airway diseases | 2024* | 14.81 |
| Total male and female | 75 to 79 years | C01D Vasodilators used in card. diseases | 2024* | 5.15 |
| Total male and female | 75 to 79 years | M05 Drugs for treatment of bone diseases | 2024* | 5.24 |
| Total male and female | 75 to 79 years | R03 Drugs for obstruct. airway diseases | 2024* | 14.78 |
| Total male and female | 80 to 84 years | C01D Vasodilators used in card. diseases | 2024* | 6.59 |
| Total male and female | 80 to 84 years | M05 Drugs for treatment of bone diseases | 2024* | 6.26 |
| Total male and female | 80 to 84 years | R03 Drugs for obstruct. airway diseases | 2024* | 14.71 |
| Total male and female | 85 to 89 years | C01D Vasodilators used in card. diseases | 2024* | 8.41 |
| Total male and female | 85 to 89 years | M05 Drugs for treatment of bone diseases | 2024* | 6.78 |
| Total male and female | 85 to 89 years | R03 Drugs for obstruct. airway diseases | 2024* | 14.45 |
| Total male and female | 90 years or older | C01D Vasodilators used in card. diseases | 2024* | 9.54 |
| Total male and female | 90 years or older | M05 Drugs for treatment of bone diseases | 2024* | 5.23 |
| Total male and female | 90 years or older | R03 Drugs for obstruct. airway diseases | 2024* | 12.46 |
| Male | Total age | C01D Vasodilators used in card. diseases | 2024* | 1.57 |
| Male | Total age | M05 Drugs for treatment of bone diseases | 2024* | 0.60 |
| Male | Total age | R03 Drugs for obstruct. airway diseases | 2024* | 7.53 |
| Male | 0 to 14 years | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Male | 0 to 14 years | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Male | 0 to 14 years | R03 Drugs for obstruct. airway diseases | 2024* | 7.36 |
| Male | 15 to 24 years | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Male | 15 to 24 years | M05 Drugs for treatment of bone diseases | 2024* | 0.01 |
| Male | 15 to 24 years | R03 Drugs for obstruct. airway diseases | 2024* | 4.18 |
| Male | 25 to 34 years | C01D Vasodilators used in card. diseases | 2024* | 0.02 |
| Male | 25 to 34 years | M05 Drugs for treatment of bone diseases | 2024* | 0.03 |
| Male | 25 to 34 years | R03 Drugs for obstruct. airway diseases | 2024* | 3.99 |
| Male | 35 to 44 years | C01D Vasodilators used in card. diseases | 2024* | 0.14 |
| Male | 35 to 44 years | M05 Drugs for treatment of bone diseases | 2024* | 0.08 |
| Male | 35 to 44 years | R03 Drugs for obstruct. airway diseases | 2024* | 4.83 |
| Male | 45 to 54 years | C01D Vasodilators used in card. diseases | 2024* | 0.75 |
| Source: CBS. | ||||
Table explanation
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Personal Records Database (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
Data are broken down by medicine group, age and sex.
Data available from: 2006
Status of the figures:
Figures for 2024 are provisional, figures for previous years are final.
Changes as of December 18, 2025:
- Provisional figures for 2024 have been added, provisional figures of 2023 have been made definite.
- Figures for 2024 do not include DDD's as they are insufficiently reliable.
When will new figures be published?
New figures will be published in the last quarter of 2026.
Description topics
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.